IL18 and choroidal neovascularization: In contrast to the well-documented release of IL-1β in response to RPE para-inflammation there is considerable debate regarding whether IL-18 contributes to or protects from AMD-associated phenotypes including choroidal neovascularization (CNV) [57,58,59,60].